ArticleResearch in social & administrative pharmacy : RSAP2018
Reliability and validity of SF-12v2 among adults with self-reported cancer.
Article in Research in social & administrative pharmacy : RSAP, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
30 citing papers in PubMed.
- Trial
- Trial
- Long-Term Outcomes, Morbidity and Quality of Life in Node-Negative Early-Stage Vulvar Cancer: Sentinel Node Biopsy versus Inguinofemoral Lymphadenectomy.Geburtshilfe und Frauenheilkunde · 2026Article
- Assessing long-term quality of life and survivorship priorities in cervical cancer patients: a social media survey-based study.Gynecologic oncology reports · 2026Article
- Implementation and Effectiveness of the Power Over Pain Portal for Patients Awaiting a Tertiary Care Consultation for Chronic Pain: Protocol for a Pilot, Prospective, Cohort, Mixed Methods Study.JMIR research protocols · 2025Article
- Patient-reported outcome measurements in facial skin surgery and a comparison between Mohs micrographic surgery and conventional excisions.Journal of the European Academy of Dermatology and Venereology : JEADV · 2025Observational
- Prospective, monocentric observational study on the clinical use and patient satisfaction of an implantable venous access Port.Langenbeck's archives of surgery · 2025Observational
- Psychometric properties of the 12-item short form health survey version 2 among general Thai samples: a Rasch analysis.Journal of pharmaceutical policy and practice · 2025Article
- Digital cognitive behavioral therapy for insomnia compared with digital patient education about insomnia in people with multiple sclerosis in Norway: study protocol for a randomized controlled trial.Sleep advances : a journal of the Sleep Research Society · 2025Article
- Improvement in physical and mental health attributable to the affordable care act.Frontiers in health services · 2025Article
- Patient-Reported Quality of Life at Diagnosis in Adolescent and Young Adults With Cancer.Journal of the National Comprehensive Cancer Network : JNCCN · 2024Article
- Development and Psychometric Validation of the Breast Cancer Stigma Assessment Scale for Women with Breast Cancer and Its Survivors.Healthcare (Basel, Switzerland) · 2024Article
- Long-term sutimlimab improves quality of life for patients with cold agglutinin disease: CARDINAL 2-year follow-up.Blood advances · 2023Article
- Fentanyl in cancer pain management: avoiding hasty judgments and discerning its potential benefits.Drugs in context · 2023Review
- Predicting health-related quality of life change using natural language processing in thyroid cancer.Intelligence-based medicine · 2023Article
- Discovering domains important to health-related quality of life in differentiated thyroid cancer.American journal of surgery · 2022Article
- The psychometric properties of the grazing questionnaire in an obesity sample with and without binge eating disorder.Journal of eating disorders · 2022Article
- Article
- Article
- Measurement properties of the 12-item Short Form Health Survey version 2 in Australians with lung cancer: a Rasch analysis.Health and quality of life outcomes · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
backgroundThe SF-12v2 has been validated in general population and other conditions but the evidence is limited in Americans with cancer.
objectiveTo assess reliability and validity of SF-12v2 among adults with self-reported cancer using the Medical Expenditure Panel Survey (MEPS).
methodsSelf-reported cancer participants (SCPs) were identified from 2003 MEPS. SF-12v2 was administered as part of self-administered questionnaires. Physical (PCS12) and mental (MCS12) component scores of SF-12v2 were evaluated for reliability (internal consistency, test-retest) and validity (convergent, discriminant, predictive, concurrent).
results420 SCPs were identified with average age of 59.3 years (SE = 0.9). 10.7% had multiple cancers (>1) and 52% had at least one other chronic condition (OCC). Average PCS12 and MCS12 were 45.09 (SE = 0.5) and 50.75 (SE = 0.5). PCS12 and MCS12 demonstrated high internal consistency (α
conclusionThe SF-12v2 is a reliable and valid instrument to quantify health-related quality of life among adults with self-reported cancer.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.